Free electrons offer chemists a new way to control reactions that conventional electron transfer rules would normally prevent. Inside a reaction flask, an electron can determine which molecules combine and which remain unchanged. Chemists rely on this control to build complex compounds used in lifesaving drugs, advanced materials, and laboratory models of biological systems. One […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]
Shape-Shifting Drug Supercharges Cancer Treatment in Mice
A shape-changing drug attacks tumors in several ways and improves outcomes in mice. A tumor is rarely made up of identical cells. As cancer progresses or adapts to treatment, different cells may display different molecular targets, allowing some to escape drugs designed to recognize only one. That diversity poses a challenge for antibody-drug conjugates, precision […]